Thus, taken together, this study implicates USP15 as a previously unknown clinically important regulator of p53-R175H mutant protein in ovarian cancer cells, and further illustrates that distinct pathways regulate the levels and stability of the different mutp53 proteins and WT-p53 in cells (Fig. 7g). This evidence concerns the gene TP53 and ovarian cancer.